Newsletter | September 5, 2008

9.5.08 -- High Performance Microplate Products For Drug Discovery

www.drugdiscoveryonline.com
Top News Stories
High Performance Microplate Products For Drug Discovery
Porvair Sciences Ltd. has announced that its will be displaying its comprehensive range of microplate products for drug discovery laboratories at the SBS/ELRIG 2008 meeting in Bournemouth, UK...

Academic Publication Highlights Method For Stabilizing The Adenosine A2a G-protein Coupled Receptor For Drug Discovery Studies
Heptares Therapeutics Ltd, the drug discovery company focused on the design and development of novel drugs based on G-protein-coupled receptors notes that a new academic publication by the research group led by one of its scientific founders (Ref. 1) further validates the potential of its proprietary technology for creating purified, functional and stable G-protein receptors (GPCRs) for drug discovery and structural studies...

San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group As First Step In Automation Initiative To Support Drug Discovery Research
Guava Technologies, Inc. announced the commencement of an agreement with Hudson Control Group to provide drug discovery researchers with an automated solution for cellular analyses...

Addrenex Pharmaceuticals' New Hires Further Company Goal To Identify New Drugs For Adrenergic Regulation
Addrenex Pharmaceuticals has made three strategic hires this month to further its goal of identifying and developing as many new drug candidates as possible over the next 18 months...

Baxter Announces Licensing Agreement For Innocoll's Gentamicin Surgical Implant In The United States
Baxter Healthcare Corporation recently announced a licensing agreement with Innocoll Pharmaceuticals Ltd, a division of Innocoll, Inc., granting Baxter exclusive rights to market and distribute the company's gentamicin surgical implant in the United States...

Curis Announces Dosing Of First Patient In Phase I Clinical Trial Of CUDC-101
Curis, Inc.a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment today announced that the first patient has been treated in a Phase I clinical trial of CUDC-101, a first-in-class small molecule drug candidate that has been designed as an inhibitor of epidermal growth factor receptor...

Mallinckrodt Baker And Rubicon Research Sign Agreement For Performance Excipient Development
Covidien, a leading global provider of healthcare products, today announced that its Mallinckrodt Baker business has entered into a licensing and commercialization agreement with drug development research specialist Rubicon Research ...

Cellumen And Mitsubishi Tanabe Pharma Corporation Collaborate In Discovery Toxicology
Cellumen, Inc., a discovery toxicology company,announced an agreement with Mitsubishi Tanabe Pharma Corporation, one of the leading pharmaceutical companies in Japan, to develop panels of biomarkers that identify toxicity early in the drug development process...

Particle Sciences Develops Zero-Order-Release Combination Device Technology
Particle Sciences Inc. recently announced the development of their "Microreservoir" technology enabling the manufacture of drug-eluting polymer medical devices that release drugs at constant rates over 30 days or more. This technology has already been used by Particles Sciences to develop drug eluting vaginal rings...

Featured Products
Filter Housings
The Pall Advanta™ range of filter housings has been specifically designed and engineered for today's manufacturing processes. These advanced housings are manufactured from 316L stainless steel and are engineered to meet the requirements of the biopharmaceutical industry.

Scientific Graphing Software: SigmaPlot® Version 11
SigmaPlot Version 11 is here! The premier graphing application now has powerful advisory statistical analysis features with more than 50 key statistical methods and more than 100 graph types. Used by more than 250,000 scientists, researchers, and engineers across a wide spectrum of disciplines for data and statistical analysis, SigmaPlot allows users to present their data using exact, publication-quality graphs and reports.

Featured Download
Datasheet: ULT Series Recirculating Chiller
ULT recirculating chillers from FTS Systems offer heat removal rates for reaction vessel cooling up to 3 times higher than other brands for almost half the price. The ULT series provides 1150 watts at –40C, while other brands max out at less than 500 watts...
Newsletter Subscription
If you do not currently receive the Drug Discovery Online newsletter and wish to become a subscriber, click here.
Advertise Online
If you are interested in advertising with Drug Discovery Online, click here for more information.